Table 1.
Demographic and clinical characteristics of patients
| Real | Sham | Total | ||
|---|---|---|---|---|
| Sex | %Female | 90% | 78% | 84% |
| Age | Mean Yrs | 54.20(8.28) | 51.67(18.19) | 53.00(13.53) |
| Duration of Illness | Mean Yrs | 12.10(7.75) | 10.10(12.81) | 11.10(10.36) |
| Antidepressants | % | 90% | 90% | 90% |
| Anticonvulsants | % | 20% | 10% | 25% |
| Opiate | % | 20% | 20% | 20% |
| NSAIDS | % | 30% | 20% | 25% |
| Benzos | % | 30% | 40% | 35% |
| Muscle Relaxants | % | 0% | 20% | 10% |
| Total # Meds | Mean | 1.90(1.66) | 1.78(0.83) | 1.84(1.30) |
The data represents gender, mean age, and duration (with standard deviations) of fibromyalgia by treatment arm. It includes the percentage of patients, by treatment arm, which were prescribed medication at unchanged doses before and during the research trial.